- Home
- GDRX vs BLTE Comparison
GDRX vs BLTE Comparison
Compare GDRX & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDRX
- BLTE
- Stock Information
- Founded
- GDRX 2011
- BLTE 2018
- Country
- GDRX United States
- BLTE United States
- Employees
- GDRX N/A
- BLTE N/A
- Industry
- GDRX Retail: Computer Software & Peripheral Equipment
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- GDRX Technology
- BLTE Health Care
- Exchange
- GDRX Nasdaq
- BLTE Nasdaq
- Market Cap
- GDRX N/A
- BLTE 2.1B
- IPO Year
- GDRX 2020
- BLTE 2022
- Fundamental
- Price
- GDRX $4.41
- BLTE $66.22
- Analyst Decision
- GDRX Buy
- BLTE Strong Buy
- Analyst Count
- GDRX 10
- BLTE 4
- Target Price
- GDRX $8.68
- BLTE $96.67
- AVG Volume (30 Days)
- GDRX 1.7M
- BLTE 48.2K
- Earning Date
- GDRX 05-08-2025
- BLTE 03-17-2025
- Dividend Yield
- GDRX N/A
- BLTE N/A
- EPS Growth
- GDRX N/A
- BLTE N/A
- EPS
- GDRX 0.04
- BLTE N/A
- Revenue
- GDRX $792,324,000.00
- BLTE N/A
- Revenue This Year
- GDRX $6.14
- BLTE N/A
- Revenue Next Year
- GDRX $6.58
- BLTE N/A
- P/E Ratio
- GDRX $110.25
- BLTE N/A
- Revenue Growth
- GDRX 5.61
- BLTE N/A
- 52 Week Low
- GDRX $4.09
- BLTE $31.01
- 52 Week High
- GDRX $9.26
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- GDRX 40.33
- BLTE 56.99
- Support Level
- GDRX $4.31
- BLTE $64.69
- Resistance Level
- GDRX $4.75
- BLTE $67.40
- Average True Range (ATR)
- GDRX 0.22
- BLTE 2.11
- MACD
- GDRX -0.01
- BLTE -0.37
- Stochastic Oscillator
- GDRX 15.75
- BLTE 30.77
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.